Gene therapy: progress in childhood disease. - Wikidata - awgldk - TriplyDB

Gene therapy: progress in childhood disease.

Gene therapy: progress in childhood disease.

http://www.wikidata.org/entity/Q37948091

about

Non viral vectors in gene therapy- an overview.Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen.AAV Infection: Protection from Cancer.

P2860

Q34668309-E8A69AA5-FC43-4D24-A627-0F08ACF31F1B Q36651903-0142506D-6936-4DCB-A509-872BB3BF8FA1 Q40457152-B0BD7C25-BC0D-4AD8-9EA6-94E2D576803E

P2860

Gene therapy: progress in childhood disease.

http://www.wikidata.org/entity/Q37948091

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Gene therapy: progress in childhood disease.

@en

Gene therapy: progress in childhood disease.

@nl

type

label

Gene therapy: progress in childhood disease.

@en

Gene therapy: progress in childhood disease.

@nl

prefLabel

Gene therapy: progress in childhood disease.

@en

Gene therapy: progress in childhood disease.

@nl

P1433

Q37948091-E9C553D8-17D1-4BD8-8015-5E394FB93A97

P1476

Q37948091-E1972522-DD73-4089-ABF8-2D928F8B4B42

P2093

Q37948091-8EA1B320-250B-4142-9CB9-678A6C1249E8

P2860

Q37948091-04C5AEC5-53DA-47F7-8950-9DBC9A21E9B8

Q37948091-0FA24C02-1356-4FB5-B157-FAC711B0007E

Q37948091-14C6501C-3667-4F49-A285-920CF339730F

Q37948091-1C47DE13-7BA2-417F-BB67-FA8417D5009F

Q37948091-1E5789B5-4F47-4B64-8E97-DCA082AF8590

Q37948091-24C1B9AE-097B-4137-8DEB-6A4D3020802A

Q37948091-24D8FABA-A9DA-4749-870B-B0EFD98E7BC6

Q37948091-27627DEE-4EF8-4554-B0F9-D21131F3422A

Q37948091-28B26CF2-9CCB-485F-B1E6-06FFEFD83338

Q37948091-3F308065-A5A8-4609-95A9-585A6D049A43

P304

Q37948091-5842FE18-0CDF-44DA-BC43-DDBE7188BC41

P31

Q37948091-A024B591-12C4-4A90-81D1-2F869C0A7D01

P356

Q37948091-9796DED5-FB67-48AB-920C-6B313391DE7B

P433

Q37948091-1DEFB2E3-E350-48F2-B3B4-29AC666F2385

P478

Q37948091-AA82BBF0-D429-41B5-99A8-DDAC9DA28938

P50

Q37948091-EBE4E1AC-A0BC-48CE-A1FD-3556B2404A87

P577

Q37948091-BA21E526-F0BC-482C-BA45-46EBDD71EF97

P5875

Q37948091-47EB2D8F-4FCA-4EB5-96AE-9C3FC430A488

P698

Q37948091-5E7F1982-258E-4D78-9D99-F944DA0537C3

P921

Q37948091-3B7B1FF0-DC2B-40FA-84C4-FD8B50803BE2

P356

J.1440-1754.2011.02204.X

P1433

Journal of Paediatrics and Child Health

P1476

Gene therapy: progress in childhood disease

@en

P2093

Samantha L Ginn

http://www.w3.org/2001/XMLSchema#string

P2860

Vision 1 year after gene therapy for Leber's congenital amaurosis

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Effect of gene therapy on visual function in Leber's congenital amaurosis

Efficacy of gene therapy for X-linked severe combined immunodeficiency

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

P304

466-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1754.2011.02204.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Ian E. Alexander

P577

2011-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51739716

http://www.w3.org/2001/XMLSchema#string

P698

22017270

http://www.w3.org/2001/XMLSchema#string

P921